Facilitating accurate and timely detection of
Diabetic Neuropathy in Your Patients
Diabetic peripheral neuropathy (DPN) is among the top ten diseases that pose heavy burdens on patients and clinicians.
85% of amputation cases due to diabetic peripheral neuropathy can be avoided with earlier detection.
Optimally managing diabetic foot disease has been a challenge to clinicians for many years, due to its complex multifactorial aetiology and lack of adequate tools to study the underlying pathology.
Nearly 50% of individuals with diabetes will develop peripheral neuropathy during their lifetime.
Peripheral neuropathy increases the risk for diabetic foot ulcers and amputations.
Vibration perception threshold (VPT) testing is a clinically validated method for early neuropathy detection.
Vibrofeel™ Biothesiometer
VIBROFEEL is a quality product from LIFEKA, a non-invasive medical equipment to detect neuropathy in human beings. Neuropathy, a medical condition that affects nerves impairing sensation, movement and functioning of glands or organs in the human body.
LIFEKA manufactures Vibrofeel, a diversified range of Digital Biothesiometer, an indispensable tool for detecting sub-clinical neuropathy in children and adolescents. Vibrofeel™ is also used to research and study highly complicated neurological conditions effectively.
Vibrofeel, a quick and portable tool, provides a more consistent stimulus intended for the screening of diabetic peripheral neuropathy (DPN) in patients with type 1 or 2 diabetes.
𝐏𝐨𝐫𝐭𝐚𝐛𝐥𝐞 - Ergonomic design makes Vibrofeel portable and easy to use.
𝐃𝐢𝐬𝐩𝐥𝐚𝐲 𝐄𝐧𝐚𝐛𝐥𝐞𝐝 - Quick and accurate screening (<10 minutes) as compared to regular Biothesiometry.
